Icon buys €8.3m stake in US firm

Clinical research company Icon will spend almost $10 million (€8.3m) to take a 70% stake in US X-ray and ultrasound specialist Beacon Bioscience.

Beacon’s technology aims to manage, process and read digital images taken during clinical trials. Icon has 34 offices in 21 countries and employs over 2,500 staff worldwide.